Reuters logo
BRIEF-Propanc Biopharma submits orphan drug designation request to FDA for treatment of ovarian cancer
2017年10月25日 / 下午12点41分 / 1 个月前

BRIEF-Propanc Biopharma submits orphan drug designation request to FDA for treatment of ovarian cancer

Oct 25 (Reuters) - Propanc Biopharma Inc-

* Propanc Biopharma submits orphan drug designation request to the US Food And Drug Administration for treatment of ovarian cancer Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below